Exenatide Therapy and the Risk of Pancreatitis and Pancreatic Cancer in a Privately Insured Population

201283 citationsJournal Article

Authors

Dana P. Goldman · University of Southern California

Matthew D. Solomon · Stanford University

Daniel McFadden · University of Southern California

Abstract

We found no association between exenatide use and either hospitalization for acute pancreatitis or pancreatic cancer in a large sample of privately insured U.S. patients.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Diabetes Treatment and Management

Publication Details

Published in: Diabetes Technology & Therapeutics

Volume 14, Issue 10, pp. 904-911

DOI: 10.1089/dia.2012.0075

Field-Weighted Citation Impact: 5.90

Command Palette

Exenatide Therapy and the Risk of Pancreatitis and Pancreatic Cancer in a Privately Insured Population

Authors

Abstract

Topics & Keywords

Publication Details